CClinicalTrials.gg
Not yet recruitingNCT06054581Updated Sep 26, 2023

Animal Bite Victims Seeking Medical Services at Concerned Hospitals

An observational study in Vaccine-Preventable Diseases, sponsored by Assiut University. Not yet recruiting. Per ClinicalTrials.gov, last updated 2023-09-26.

Sponsored by Assiut University · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
662
Sex
All
01

Study summary

The goal of this observational study is to study the magnitude of the animal bite problem during one year ,to determine the percentage of compliance for full PEP doses and factors affecting the health seeking behavior among these victims.

To assess the management of the wound (first aid management done by the patient and in the hospital).

Participants will be asked to answer a questionnaire consisting of five parts and followed for completing their anti-rabies vaccination schedule.

Read the detailed description

Animal bites pose a major public health problem in children and adults worldwide. Numerous animal species have the potential to bite humans leading to rabies which is a disease of mammals , including dogs, wolves, foxes, cats, lions, mongooses, bats, monkeys and humans, However, the use of dogs as pets or companions, and for security, hunting, and breeding has contributed to their growing population.

Surveillance data revealed that people in Egypt experience a large number of animal bites annually with more than 200,000 animal bites recorded each year mostly from dogs. On average 60 people die annually from rabies in Egypt.

Rabies is 100% fatal disease but can be prevented with successful rabies control program which comprise of three pillars:1. Community participation; education, public awareness. 2. Access to mass vaccination of dogs. 3. Access to post bite treatment.

PEP is the administration of wound care and immunization after potential exposure to the rabies virus.

As a part of zero by 30 strategy set by WHO to control dog-mediated human rabies by 2030, the strategic advisory group of experts of the WHO needed the current scenario of health-seeking behavior of exposed individuals and the use of rabies vaccines and immunoglobulin in rabies endemic countries. In this regard, perception of victims and their attitude towards treatment forms an important role for prevention against rabies. It is also necessary to detect trends to evaluate the effect of preventive efforts implemented by the Ministry of Health.

02

Conditions studied

  • Vaccine-Preventable Diseases

Keywords

  • animal bite, vaccine compliance
03

In context

Vaccine-Preventable Diseases

51 studies on the registry are indexed under Vaccine-Preventable Diseases; 13 are open to participants now.

This study's planned enrollment of 662 is above the median of 295 across 12 observational studies indexed under Vaccine-Preventable Diseases.

Browse Vaccine-Preventable Diseases studies →

Lead sponsor

Assiut University is the lead sponsor of 4,901 studies on the registry; 2,098 are open to participants now.

Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

victims who recently exposed to animal bite attending to receive their first vaccination dose

Inclusion criteria

  • victims recently exposed to bite by any animal causing rabies

Exclusion criteria

Exclusion Criteria:

  • other types of animal bites
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
662 participants (estimated)
Patient registry
No

Interventions

  • Behavioralhealth seeking behavior

    health seeking behavior in the form of wound management and receving anti rabies immunization

06

What researchers measure

Primary outcomes

  1. anti-rabies vaccination compliance among animal bite victims

    follow up of victims coming to receive their vaccination for the first time

    Time frame: each patient will be followed for 2 months after the first visit till completing the required sample

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Kenu E, Ganu V, Noora CL, Adanu R, Lartey M. Management of dog bites by frontline service providers in primary healthcare facilities in the Greater Accra Region of Ghana, 2014-2015. Infect Dis Poverty. 2018 Feb 28;7(1):18. doi: 10.1186/s40249-018-0398-3. PubMed 29502522 ↗
  • Jakasania AH, Mansuri FM, Dixit GT. An association of knowledge and misconceptions with health seeking behaviour for dog bite: a cross-sectional study in Ahmedabad. Int J Comm Med Public Heal. 2017 Jun 23;4(7):2592-5.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 26, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06054581
Lead sponsor
Assiut University
Responsible party
alyaa abdelaal mohamed abdelaal (assisstant lecturer, Assiut University) — Principal investigator
First posted
Sep 26, 2023
Start date
Jan 2024 (estimated)
Primary completion
Dec 2027 (estimated)
Completion
Dec 2028 (estimated)
Last update
Sep 26, 2023

Study contacts

alyaa Abdelaal, PhD
Contact
alyaaabdelaal@yahoo.com
+201092777031
alyaa abdelaal
study chair · Assiut University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion